|
|
||||||||
Ann Thorac Surg 2006;82:146-152
© 2006 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, Children's Hospital, Harvard Medical School, Boston, Massachusetts
b Department of Anesthesiology, Children's Hospital, Harvard Medical School, Boston, Massachusetts
c Department of Biostatistics, Children's Hospital, Harvard Medical School, Boston, Massachusetts
d Department of Cardiovascular Surgery, Saiseikai Kyotofu Hospital, Tokyo, Japan
Accepted for publication February 2, 2006.
* Address correspondence to Dr Takeuchi, Department of Cardiovascular Surgery, National Children's Hospital, Japan, 2-10-1 Ohkura, Setagaya, Tokyo, 157-8535, Japan (Email: koutakeuchi-circ{at}umin.ac.jp).
| Abstract |
|---|
|
|
|---|
METHODS: From January 1992 to May 1999, medical records of 96 patients (50 males, 46 females) who had complex double-outlet right ventricle with heterotaxy and/or complete atrioventricular canal defect were reviewed (median age at initial surgery 3 months). Seventeen patients were neonates requiring surgery. Follow-up ranged from 1 day to 7.4 years (median, 16 months).
RESULTS: Sixty-eight patients had heterotaxy syndrome (27 with total anomalous pulmonary venous connection). Eighty-three had complete atrioventricular canal defect, 22 with moderate to severe atrioventricular valve regurgitation at the time of surgical repair. Eight patients had two-ventricle repair, and 88 patients were considered for single-ventricle management (bidirectional Glenn, 37; Fontan, 44). One patient had heart transplantation after bidirectional Glenn. There were 16 deaths including 10 early (<30 days postoperatively). Overall survival (95% confidence interval) estimated by the KaplanMeier method was 89% (83% to 96%) at 1 month, 84% (76% to 91%) at 1 year, and 81% (73% to 89%) at 5 years. Multivariate analysis revealed that neonatal presentation requiring surgery (p < 0.0001), moderate to severe atrioventricular valve regurgitation (p = 0.03), and pulmonary venous obstruction (p = 0.02) were risk factors for death.
CONCLUSIONS: Atrioventricular valve regurgitation, pulmonary venous obstruction, and neonatal presentation are risk factors for mortality in patients with complex double-outlet right ventricle. Early surgical intervention in symptomatic neonates and infants, including those with pulmonary venous obstruction, may reduce mortality and improve outcome after staged operation.
| Introduction |
|---|
|
|
|---|
This study was undertaken to assess the significance of associated lesions in complex forms of DORV on early and intermediate term mortality and the role of aggressive early surgical intervention, particularly with the management of TAPVC.
| Material and Methods |
|---|
|
|
|---|
Statistical Analysis
The following 21 variables were tested: sex, age at the time of operation, heterotaxy syndrome, CAVC defect, TAPVC, pulmonary venous obstruction, pulmonary stenosis, pulmonary atresia, coarctation of the aorta, hypoplastic aortic arch, AV valve regurgitation (AVVR) and discordance, criss-cross heart, straddling AV valve, double-chambered right ventricle, patent ductus arteriosus, atrial septal defect, subaortic stenosis, persistent left superior vena cava, dextrocardia, and year of operation. A backward likelihood ratio procedure was applied to build the multivariable model. Fisher's exact test was used to compare proportions. Estimated rates of survival were determined using the KaplanMeier product-limit method with 95% confidence intervals (CI) calculated by Greenwood's formula (as reported in [5]). The Cox proportional-hazards regression model was used to establish the variables independently associated with mortality, and risk was measured by the adjusted risk ratio [6]. Data were analyzed with the SPSS software package (version 10.1, SPSS Inc, Chicago, IL). All reported probability values are two-tailed.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
Overall survival estimated by the KaplanMeier method was 89% (95% CI, 83% to 96%) at 1 month, 84% (95% CI, 76% to 91%) at 1 year, and 81% (95% CI, 73% to 89%) at 5 years. The KaplanMeier survival curve is presented in Figure 3. The 21 variables tested for significance in the univariate analysis and multivariate analyses are shown in Table 4. Multivariate analysis using the Cox model revealed that neonatal presentation requiring surgery (p < 0.0001), moderate or severe AVVR (p = 0.03), and pulmonary venous obstruction (p = 0.02) were risk factors for death. The monthly odds of death were estimated to be more than 13 times higher for neonates requiring surgery compared with patients operated on after 30 days of life (risk ratio, 13.9; 95% CI, 5.3 to 36.5; p < 0.0001). Patients with moderate or severe AVVR at the time of surgery were estimated to be more than four times more likely to die (risk ratio, 4.1; 95% CI, 1.6 to 14.8; p = 0.03). Patients with pulmonary venous obstruction were estimated to be more than four times more likely to die (risk ratio, 4.9; 95% CI, 1.3 to 17.4; p = 0.02). The year of surgery was also found to be a significant predictor inasmuch as more recent surgeries were associated with a better odds of patient survival (risk ratio, 0.7; 95% CI, 0.6 to 0.9; p = 0.007). None of the other variables tested including aortic arch hypoplasia or coarctation, pulmonary stenosis or atresia, subaortic stenosis, and TAPVC was identified to be a risk factor of mortality.
|
| Comment |
|---|
|
|
|---|
Double-outlet right ventricle encompasses a broad spectrum of anatomic variants and associated malformations. Heterotaxy syndrome, which is often associated with TAPVC and CAVC, has been considered a risk factor for surgical repair of DORV. The early and mid-term outcomes for children with functional single ventricle have markedly improved in recent years even in patients with heterotaxy syndrome [3]. Since the introduction of the Fontan procedure in the early 1970s, modifications of surgical techniques, such as total cavopulmonary connection with a lateral tunnel and tunnel fenestration [7], along with improved patient selection and perioperative management [8] have resulted in significant decreases in both early and mid-term mortality. The use of staged reconstruction with an intermediate bidirectional Glenn connection [9] has further reduced overall mortality. We prefer to create bidirectional Glenn connection before the Fontan procedure in most patients who have single-ventricle physiology to reduce postoperative morbidity and mortality. But this is not true for some patients, who can undergo straight Fontan with reasonable risk. In the later series of this study, bidirectional Glenn procedure became a more popular procedure than before. This might be an explanation for the number of straight Fontan patients.
Previous reports have suggested that the association of TAPVC with single ventricle, particularly in patients with heterotaxy syndrome, is a risk factor for poor outcome [1012]. In a recent report, Gaynor and colleagues [13] suggested that factors influencing survival of patients with heterotaxy syndrome undergoing the Fontan procedure included greater than mild AV regurgitation, hypoplastic pulmonary arteries, and high pulmonary artery pressure after 6 months of age. They postulated that inadequate development of the pulmonary vasculature, especially the pulmonary veins, occurring even in children without clinical evidence of pulmonary venous obstruction, resulted in high early mortality and a continuing risk for late death. Their more recent report suggested an improvement of surgical result for patients with single ventricle and TAPVC [14]. Most of the patients in our study were managed as having single-ventricle physiology, and 68 patients had heterotaxy, with 27 of the 68 (40%) having TAPVC. Although we did not include all children with heterotaxy and single-ventricle physiology, our group of patients is similar to that reported by Gaynor and associates [13]. In a previous report from our institution, neither the presence of TAPVC nor TAPVC repair was found to be a definite risk factor for early death in newborn patients with TAPVC and visceral heterotaxy [11]. We did not find the presence of TAPVC to be a risk factor for mortality in this study, but obstruction of the pulmonary veins was a significant risk factor. Five of 13 patients with obstructed TAPVC died (mortality, 38%), and 4 patients were neonates. One explanation for the finding that the presence of TAPVC was not found to be a risk factor in our cohort may be the timing of surgical repair of TAPVC. Of the 30 children with TAPVC, all but 8 had the pulmonary veins connected to the atrium at a surgical procedure before the Fontan operation, with 1 death in the Fontan group (Fig 2). One may speculate that subtle degrees of obstruction result in elevated or labile pulmonary vascular resistance postoperatively in the children with unrepaired TAPVC at the time of the Fontan procedure. If so, then a more aggressive approach with early repair of anomalous pulmonary venous connection is warranted.
The presence of CAVC defect frequently limits the ability to achieve a two-ventricle repair, particularly when associated with unbalanced ventricular chambers [15]. Atrioventricular regurgitation is known to be a risk factor for Fontan operation [16]. The natural history of common AVVR in patients with functional single ventricle is poor. Moak and Gersony [16] reported that AVVR was a significant and specific complicating factor that developed in patients with single ventricle and common AV valve. In a similar report with 242 patients undergoing a Fontan procedure including 99 patients with AVVR, Imai and associates [17] reported a significantly higher mortality in children who had AVVR compared with those without AVVR, even if valve repair was attempted. In our study, 64 patients had mild or worse valve regurgitation including 22 patients with moderate or severe AVVR. Eleven of the 22 patients with greater than mild regurgitation underwent AV valve surgery, including 2 patients requiring valve replacement. Seven of 11 patients who underwent atrioventricular valve repair or replacement died after the surgery. Two patients died of ventricular failure before Fontan palliation and another patient who also did not undergo Fontan procedure died on postoperative day 26, probably related to the high pulmonary vascular resistance. But other patients died of variable diseases including late cardiac tamponade, thrombosed valve, sepsis, and intracranial hemorrhage. Clearly, 2 deaths were related to ventricular dysfunction and another to high pulmonary vascular resistance. Younger children, particularly neonates who have high pulmonary vascular resistance, may rapidly progress to obstructive pulmonary disease. Imai and associates [17] reported the same findings as ours that AVVR would be risk factor for death even if it was repaired. They also found that ventricular dysfunction was not rare after repair of AV valve. Although we do not have a clear explanation for this, ventricular dysfunction may be related to relative increase of afterload and reduced ventricular volume. We found that moderate to severe AVVR was a significant risk factor of mortality with 7 deaths among the 22 children having valve repair alone or in conjunction with other surgical procedures.
Another independent risk factor for mortality found in this study is symptomatic neonatal presentation with 7 deaths early and 1 late in the group of 17 newborns. The observation that 4 of the 7 children with obstructed pulmonary venous return died early after surgery reflects the difficulty in regulating pulmonary blood flow with shunt-dependent pulmonary circulation and labile pulmonary vascular resistance and pulmonary edema. Conversely, the fact that the other 3 neonates with obstructed TAPVC, 1 of whom also had a Norwood procedure, are long-term survivors suggests that early surgical intervention to palliate all the critical anatomic defects may be warranted.
This study has several limitations. It is retrospective, and the data are limited by the review of the medical records. To ensure inclusion of all patients, we reviewed multiple sources including the echocardiography, surgical, and cardiac catheterization databases.
In conclusion, this study demonstrates that children having complex forms of DORV including heterotaxy and/or CAVC defect can be treated with reasonable risk for surgery. Atrioventricular valve regurgitation, pulmonary venous obstruction, and neonatal presentation are independent risk factors for mortality. Although high mortality was seen in symptomatic neonates even with surgical intervention, the monthly odds of death were estimated to be more than 13 times higher for neonates requiring surgery compared with patients operated on after 30 days of life, and there were survivors of neonates with surgical intervention. Thus, early surgical intervention for symptomatic neonates may reduce mortality and improve outcome after a staged operation.
| The Society of Thoracic Surgeons: Forty-Third Annual Meeting |
|---|
|
|
|---|
Advance registration forms, hotel reservation forms, and details regarding transportation arrangements, as well as the complete meeting program, will be mailed to Society members this fall. Also, complete meeting information will be available on the Society's Web site at www.sts.org. Nonmembers who wish to receive information on the Annual Meeting may contact the Society's secretary, Douglas E. Wood.
Abstracts for the meeting must be submitted electronically. The electronic submission form may be accessed at www.sts.org. There is no charge for submitting abstracts. The submission deadline is June 30, 2006 at 5:00 PM CDT. Please direct any questions regarding your submission to the Society's headquarters.
Douglas E. Wood, MD Secretary
The Society of Thoracic Surgeons
633 N. Saint Clair St, Suite 2320
Chicago, IL 60611-3658
Telephone: (312) 202-5800
Fax: (312) 202-5801
e-mail: mailto:sts{at}sts.org
website: www.sts.org
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. V. Anagnostopoulos, J. M. Pearl, C. Octave, M. Cohen, A. Gruessner, E. Wintering, and M. F. Teodori Improved current era outcomes in patients with heterotaxy syndromes Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 871 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Shuhaiber, S. Y. Ho, M. Rigby, and B. Sethia Current options and outcomes for the management of atrioventricular septal defect Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 891 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.G. Lim, E.A. Bacha, G.R. Marx, A. Marshall, F. Fynn-Thompson, J.E. Mayer, P. Del Nido, and F.A. Pigula Biventricular repair in patients with heterotaxy syndrome. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 371 - 379.e3. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |